Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent

Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4

(2012) Y.-C. Wu et al.   CANCER RESEARCH

Lessons learned from testicular cancer: Identification of cytoplasmic p21 as an Achilles' heel of cisplatin resistance 

(2011) Roelof Koster et al.   CELL CYCLE

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin

(2011) Matthias Gutekunst et al.   PLoS One

Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway

(2011) R Koster et al.   Cell Death & Disease

p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors

(2010) Baozong Li et al.   CELL CYCLE

Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer

(2010) Roelof Koster et al.   JOURNAL OF CLINICAL INVESTIGATION

Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours

(2009) Sebastian Bauer et al.   EUROPEAN UROLOGY